Interaction Checker

Two additional drugs have been added to the interaction checker

Wednesday 21 February 2018

Cobimetinib and vemurafenib are now listed in the interaction checker as cancer drugs and interactions can be found with all the comedications. 

  • Cobimetinib (Cotellic®) is a MEK inhibitor and is indicated for the treatment of melanoma.
  • Vemurafenib (Zelboraf®) is BRAF inhibitor and is indicated for the treatment of melanoma. 
ENDORSED BY
Bopa